Vidarabine
ADVERTISEMENT
- Molecular formula
- C10H7N5O4
- CAS Number
- 5536-17-4
- IUPAC Name
- 4-amino-2-[6-(dimethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3-ol
- Molecular Weight
- 267.27g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.5950g/cm3
- Synonyms
- ARDMA
Identification
Interesting facts
Interesting Facts about 4-amino-2-[6-(dimethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3-ol
This intriguing compound, often referred to in shorthand as a purine derivative, has garnered considerable interest in the field of medicinal chemistry due to its unique structure and potential applications:
- Purine Base Connection: As a purine derivative, this compound has structural similarities to DNA and RNA bases, making it essential in the study of nucleic acids and their analogs.
- Biological Activity: Compounds that contain purine structures are often involved in various biological processes, including cell signaling, energy transfer (as seen in ATP), and important interactions in cellular metabolism.
- Potential Therapeutic Applications: Research suggests that modifications to purine structures can lead to anti-cancer and antiviral agents, hence this compound could serve as a lead in drug design.
- Dimethylamino Group Impact: The presence of the dimethylamino group is significant, as it could affect the compound's solubility and permeability, crucial for pharmacokinetics.
- Hydroxymethyl Tetrahydrofuran: The incorporation of a hydroxymethyl group and a tetrahydrofuran ring not only adds to the compound's complexity but also suggests potential for interaction with various biological targets.
In summary, 4-amino-2-[6-(dimethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3-ol is more than just a chemical entity; it represents a crucial intersection of chemistry and biology with the potential for significant contributions to therapeutic development. As one researcher aptly stated, “the key to unlocking future therapies often lies within the tiny structures of purine derivatives.”